» Authors » R Tung

R Tung

Explore the profile of R Tung including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 259
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Linke A, Mash L, Fong C, Kinnear M, Kohli J, WILKINSON M, et al.
Neuroimage . 2020 Sep; 223:117383. PMID: 32949710
Resting state fMRI (rsfMRI) is frequently used to study brain function, including in clinical populations. Similarity of blood-oxygen-level-dependent (BOLD) fluctuations during rsfMRI between brain regions is thought to reflect intrinsic...
2.
Webb K, Tung R, Winterfield L, Gottlieb A, Eby J, Henning S, et al.
Br J Dermatol . 2015 Jul; 173(3):641-50. PMID: 26149498
Tumour necrosis factor (TNF)-α, a proinflammatory cytokine central to many autoimmune diseases, has been implicated in the depigmentation process in vitiligo. We review its role in vitiligo by exploring its...
3.
Tung R, Boyle N
Minerva Cardioangiol . 2008 Dec; 56(6):653-7. PMID: 19092740
Atrial fibrillation frequently coexists with heart failure, and these two chronic disease states often physiologically exacerbate one another. Clinical trials comparing rate versus rhythm control strategies have not demonstrated superiority...
4.
Yau T, Soong I, Chan K, Chang A, Sze H, Yeung M, et al.
Breast . 2007 Sep; 17(1):58-63. PMID: 17804235
Incorporating various new and conventional risk factors, the 2005 St Gallen risk categorization is a potentially useful prognostic tool for breast cancers. We conducted a retrospective study to evaluate its...
5.
Goldberger J, Challapalli S, Tung R, Parker M, KADISH A
Circulation . 2001 Apr; 103(15):1977-83. PMID: 11306527
Background: Baroreflex-mediated parasympathetic stimulation has variable effects on heart rate variability (HRV). We postulated that a quadratic function would describe the relationship between HRV and parasympathetic effect better than a...
6.
Gulick R, Smeaton L, DAquila R, Eron J, Currier J, Gerber J, et al.
J Infect Dis . 2001 Feb; 183(5):715-21. PMID: 11181147
This prospective, multicenter, open-label study was designed to determine the antiretroviral activity and safety of a 4-drug regimen: 1000 mg indinavir every 8 h with 200 mg nevirapine, 40 mg...
7.
Markland W, Rao B, Parsons J, Black J, Zuchowski L, Tisdale M, et al.
J Virol . 2000 Jul; 74(16):7636-41. PMID: 10906218
Recent drug regimens have had much success in the treatment of human immunodeficiency virus (HIV)-infected individuals; however, the incidence of resistance to such drugs has become a problem that is...
8.
Eron Jr J, Smeaton L, Fiscus S, Gulick R, Currier J, Lennox J, et al.
J Infect Dis . 2000 Apr; 181(5):1622-8. PMID: 10783117
Antiretroviral therapy may lead to decreased shedding of human immunodeficiency virus type 1 (HIV-1) in genital secretions. Thirty men, 19 receiving amprenavir and 11 receiving amprenavir, zidovudine, and lamivudine, donated...
9.
Tayapiwatana C, Tung R
Asian Pac J Allergy Immunol . 2000 Mar; 17(4):301-6. PMID: 10698471
Double-particle reversed passive hemagglutination (RPHA) was performed for the detection of an intact heterodimeric form of human chorionic gonadotropin (intact hCG) composed in Profasi hCG (P-hCG). This technique relied on...
10.
Murphy R, Gulick R, Degruttola V, DAquila R, Eron J, Sommadossi J, et al.
J Infect Dis . 1999 Mar; 179(4):808-16. PMID: 10068575
Amprenavir is a human immunodeficiency virus (HIV) protease inhibitor with a favorable pharmacokinetic profile and good in vitro activity. Ninety-two lamivudine- and protease inhibitor-naive individuals with >/=50 CD4 cells/mm3 and...